Veltassa (Patiromer) Approved in Japan for the Treatment of Adults With Hyperkalemia
Down 6% in a Month: Is It Time to Buy CSL Shares?
Why The 20% Return On Capital At Carlisle Companies (NYSE:CSL) Should Have Your Attention
Oppenheimer Maintains Carlisle Companies(CSL.US) With Buy Rating, Maintains Target Price $480
A Quick Look at Today's Ratings for Carlisle Companies(CSL.US), With a Forecast Between $430 to $500
Oppenheimer Sticks to Its Buy Rating for Carlisle Companies (CSL)
Jefferies Maintains Carlisle Companies(CSL.US) With Hold Rating, Raises Target Price to $430
Loop Capital Maintains Carlisle Companies(CSL.US) With Buy Rating, Maintains Target Price $475
Carlisle Companies Releases Carlisle Campus Tour Presentation
Carlisle Companies' (NYSE:CSL) 25% CAGR Outpaced the Company's Earnings Growth Over the Same Five-year Period
Goldman's 'Goldilocks' Mid-cap Picks That Trade at Reasonable Valuations
Apollo Global, Coinbase, Workday, Trade Desk Could Get Added to S&P 500 Index
Oppenheimer Lists Best Stock Ideas Into the 2024 U.S. Elections
Looking Into Carlisle Companies's Recent Short Interest
Carlisle Expected to Show Solid Growth, Margin Expansion, Oppenheimer Says
Carlisle Companies Analyst Ratings
Oppenheimer Maintains Carlisle Companies(CSL.US) With Buy Rating, Raises Target Price to $480
Winchester Carlisle Companies Announces Investment Partnership
3 of the Best ASX 200 Retirement Shares to Buy in September
These 4 Measures Indicate That Carlisle Companies (NYSE:CSL) Is Using Debt Safely